Sun Pharmaceutical Industries Limited at its board meeting held on May 26, 2023, recommended final dividend of INR 4.00 per equity share of INR l each of the Company for financial year 2022-2023, subject To Approve the shareholders at the upcoming 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,532 INR | +0.03% | +0.45% | +21.63% |
05-09 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
05-08 | Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner Secunderabad, Telangana | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B | |
+6.11% | 4.77B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Recommends Final Dividend for Financial Year 2022-2023